MétaCan
Menu
Back to cohort
Record W4414786640 · doi:10.1093/neuonc/noaf193.347

P11.08.A CLINICAL OUTCOMES AND BIOMARKER SHIFTING OF BREAST CANCER BRAIN METASTASES - A SINGLE INSTITUTION EXPERIENCE

2025· article· en· W4414786640 on OpenAlexaff
Rui Wang, Qing Zhang, JF Megyesi

Bibliographic record

VenueNeuro-Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicBrain Metastases and Treatment
Canadian institutionsWestern University
Fundersnot available
KeywordsBreast cancerUnivariate analysisMedical diagnosisMultivariate analysisRetrospective cohort studyDiseaseStage (stratigraphy)BiomarkerCancerBiopsy

Abstract

fetched live from OpenAlex

Abstract BACKGROUND Breast cancer brain metastases (BCBMs) are a feared complication of breast cancer and associated with a poor prognosis. The molecular and biological events that give rise to BCBMs are not fully understood. The project aims are to characterize the clinicopathological outcomes of patients who underwent surgical resection or biopsy of BCBMs at London Health Sciences Centre (LHSC) and further compare the biomarker profiles between primary tumor and BM. MATERIAL AND METHODS Patients who had BCBMs surgically-resected or biopsied at LHSC were identified. Retrospective chart review was conducted to collect patients demographics, details on primary BC and BM diagnoses and treatments, pathology details, and clinical outcomes. Kaplan-Meier curves were generated and uni- and multivariate Cox-regression analyses were conducted to determine clinical outcome predictors. RESULTS Seventy-five female patients were identified. Mean age at BCBM diagnosis was 56.1 years and mean time to developing BCBM was 5.4 years (range: 0-23.0 years). Triple-negative (18/75, 24.0%) and HER2+ (14/75, 18.7%) were the most common subtypes. Median overall survival (OS) after BCBM diagnoses was 2.4 years. Solitary BCBM (p=0.0276) and no extracranial systemic disease (p=0.0276) were associated with longer OS after BCBM diagnosis. 51 patients had paired immunohistochemistry (IHC) markers of their primary BC and BMs. 12/51 (23.5%) patients exhibited a subtype switch with hormone receptor loss (5/12, 41.7%) being the most common change. Univariate Cox-regression analyses for these 51 patients demonstrated that triple-negative subtype (HR 2.81, p=0.0075), multiple BMs (HR 3.23, p=0.0024), neurological deficits (HR 3.06, p=0.0058), tumor >3 cm (HR 2.84, p=0.013), and hydrocephalus (HR 4.13, p=0.014) were negative prognostic factors. After multivariate Cox-regression, only triple-negative subtype (3.52, p=0.0033) and multiple BMs (2.34, p=0.047) remained significant. Subtype switching did not appear to impact OS (p=0.27). CONCLUSION The management of BCBM remains challenging with overall survival remaining poor, especially in those with triple-negative disease, multiple BMs, and widespread metastatic disease. Within our cohort, a noticeable proportion of patients exhibited biomarker profile shifting between the primary BC and BCBM. This may have clinical implications and further investigations are required.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.066
GPT teacher head0.413
Teacher spread0.347 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicBrain Metastases and TreatmentFrench-language works237,207